Explainable Machine Learning (XAI) for Survival in Bone Marrow Transplantation Trials: A Technical Report
Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Alessandro Busca(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Sofia Zompi(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Jessica Gill(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 4
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
|Leukemia|2013|305
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation
|New England Journal of Medicine|2014|301